User profiles for Joseph D. Butner
Joseph D ButnerAssistant Professor, MD Anderson Cancer Center Verified email at mdanderson.org Cited by 974 |
Simulating cancer growth with multiscale agent-based modeling
There have been many techniques developed in recent years to in silico model a variety of
cancer behaviors. Agent-based modeling is a specific discrete-based hybrid modeling …
cancer behaviors. Agent-based modeling is a specific discrete-based hybrid modeling …
[HTML][HTML] Mathematical modeling in cancer nanomedicine: a review
Cancer continues to be among the leading healthcare problems worldwide, and efforts
continue not just to find better drugs, but also better drug delivery methods. The need for …
continue not just to find better drugs, but also better drug delivery methods. The need for …
[HTML][HTML] A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery
Towards clinical translation of cancer nanomedicine, it is important to systematically investigate
the various parameters related to nanoparticle (NP) physicochemical properties, tumor …
the various parameters related to nanoparticle (NP) physicochemical properties, tumor …
Integrated PK-PD and agent-based modeling in oncology
Mathematical modeling has become a valuable tool that strives to complement conventional
biomedical research modalities in order to predict experimental outcome, generate new …
biomedical research modalities in order to predict experimental outcome, generate new …
Innate immunity plays a key role in controlling viral load in COVID-19: mechanistic insights from a whole-body infection dynamics model
…, J Ruiz-Ramírez, K Sinha, JD Butner… - ACS pharmacology & …, 2020 - ACS Publications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pathogen of immense
public health concern. Efforts to control the disease have only proven mildly successful, and …
public health concern. Efforts to control the disease have only proven mildly successful, and …
Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy
We present a mechanistic mathematical model of immune checkpoint inhibitor therapy to
address the oncological need for early, broadly applicable readouts (biomarkers) of patient …
address the oncological need for early, broadly applicable readouts (biomarkers) of patient …
[HTML][HTML] Theory and experimental validation of a spatio-temporal model of chemotherapy transport to enhance tumor cell kill
It has been hypothesized that continuously releasing drug molecules into the tumor over an
extended period of time may significantly improve the chemotherapeutic efficacy by …
extended period of time may significantly improve the chemotherapeutic efficacy by …
Mechanistic modeling identifies drug-uptake history as predictor of tumor drug resistance and nano-carrier-mediated response
A quantitative understanding of the advantages of nanoparticle-based drug delivery vis-à-vis
conventional free drug chemotherapy has yet to be established for cancer or other …
conventional free drug chemotherapy has yet to be established for cancer or other …
Mathematical modeling of cancer immunotherapy for personalized clinical translation
Encouraging advances are being made in cancer immunotherapy modeling, especially in
the key areas of developing personalized treatment strategies based on individual patient …
the key areas of developing personalized treatment strategies based on individual patient …
A mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burden
A large proportion of patients with cancer are unresponsive to treatment with immune
checkpoint blockade and other immunotherapies. Here, we report a mathematical model of the …
checkpoint blockade and other immunotherapies. Here, we report a mathematical model of the …